Greater use of next generation sequencing can better prepare the world for future diseases and accelerate the adoption of precision care.
As organizations continue to use technology to enhance the way they provide care, changes must be made to ensure the interoperability of the technology, patient data and continuity between providers.
Automating validation processes gives manufacturers the flexibility and capability to make changes, updates and re-validation, making it easier to upgrade or add new MES modules to their process. Simplifying the process through automation leads to faster ROI and time to market.
Adding wireless connectivity to medical devices brings convenience to patients, and can facilitate more effective healthcare delivery and lower healthcare costs. Its success depends on the ability of manufacturers to produce reliable, connected products that do not fail prematurely in the field.
Digital twins have the capability to enable safer medical devices and improve overall patient outcomes.
As the pace of innovation further accelerates in 2021, and the need to get new devices to market intensifies, maintaining adherence to regulatory controls is not enough.
Digital health tools and technology have the potential to dramatically improve the patient care experience, but the shift requires purposeful coordination and planned architecture.
We all need to play a role to drive the innovative changes necessary and not wait for someone else to do it.
When a company does not take action to become more environmentally responsible, it risks losing access to global markets.
The program highlights the agency’s commitment to improving safety and supporting innovation, and is a welcome counterpart to the Breakthrough Devices Program.
